TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Biospecialisten Sverige AB
Closing information (x1000 DKK)
| Closing information | 2025/04 | 2024/04 | 2023/04 |
| Turnover |
890
|
652
|
803 |
| Financial expenses |
22
|
23
|
11 |
| Earnings before taxes |
61
|
-46
|
-72 |
| EBITDA |
124
|
9
|
-61 |
| Total assets |
283
|
310
|
296 |
| Current assets |
58
|
60
|
80 |
| Current liabilities |
146
|
238
|
174 |
| Equity capital |
137
|
72
|
122 |
| - share capital |
68
|
63
|
66 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2025/04 | 2024/04 | 2023/04 |
| Solvency |
48.4%
|
23.2%
|
41.2% |
| Turnover per employee |
890
|
652
|
803 |
| Profit as a percentage of turnover |
6.9%
|
-7.1%
|
-9.0% |
| Return on assets (ROA) |
29.3%
|
-7.4%
|
-20.6% |
| Current ratio |
39.7%
|
25.2%
|
46.0% |
| Return on equity (ROE) |
44.5%
|
-63.9%
|
-59.0% |
| Change turnover |
191
|
-122
|
-502 |
| Change turnover % |
27%
|
-16%
|
-38% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/04 | 2024/04 | 2023/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.